Syneron Medical (ELOS)

8.90 -0.01  -0.11%  May 20, 8:00PM
Add to Watchlists Create an Alert

Syneron Medical R&D Expense Quarterly:

8.306M for Dec. 31, 2012
View Full Chart

Syneron Medical R&D Expense Quarterly Chart

    Syneron Medical Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 8.306M
    Sept. 30, 2012 7.206M
    June 30, 2012 7.731M
    March 31, 2012 6.693M
    Dec. 31, 2011 6.783M
    Sept. 30, 2011 7.027M
    June 30, 2011 8.156M
    March 31, 2011 6.368M
    Dec. 31, 2010 6.414M
    Sept. 30, 2010 6.672M
    June 30, 2010 6.721M
    March 31, 2010 7.03M
    Dec. 31, 2009 4.271M
    Sept. 30, 2009 3.063M
    June 30, 2009 2.938M
    March 31, 2009 2.948M
    Dec. 31, 2008 3.15M
    Sept. 30, 2008 3.646M
       
    June 30, 2008 3.601M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ELOS R&D Expense Quarterly Benchmarks

    Companies
    Cynosure 3.781M
    Solta Medical 5.335M
    Cutera 2.121M

    ELOS R&D Expense Quarterly Rankings

    Overall 91st percentile
    654 of 8002
    Sector 73rd percentile
    174 of 650 in Healthcare
    Industry 75th percentile
    22 of 90 in Medical Devices

    ELOS R&D Expense Quarterly Range, Past 5 Years

    Minimum 2.938M Jun 2009
    Maximum 8.306M Dec 2012
    Average 5.722M